dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 22, 2026

Intel Reports Fourth-Quarter and Full-Year 2025 Financial Results

View original at finance.yahoo.com
“Client Computing Group (CCG) $8.2 billion down 7% $32.2 billion down 3%”
Verbatim excerpt from the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Intel exceeded Q4 expectations across revenue, gross margin, and EPS even while navigating industry-wide supply shortages

    80% confidence

  • Intel is the only company with R&D, design, and HVM of leading-edge logic semiconductors at leading nodes in USA

    80% confidence

  • Strong customer demand exists for Intel 18A

    80% confidence

  • Rapid AI adoption is reinforcing x86 importance

    80% confidence

  • Intel delivered a solid finish to the year and made progress on journey to build a new Intel

    80% confidence

  • Our conviction in the essential role of CPUs in the AI era continues to grow

    80% confidence

  • Intel expects available supply to be at its lowest level in Q1 before improving in Q2 and beyond

    80% confidence

  • Demand fundamentals across Intel's core markets remain healthy

    80% confidence

  • x86 is the world's most widely deployed high-performance compute architecture

    80% confidence

  • Intel 18A is the most advanced process technology developed and manufactured in the United States

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Intel Reports Fourth-Quarter and Full-Year 2025 Financial Results: Source | Via News | fr.via.news